Amaç: Prostat kanseri erkeklerde en sık görülen kanserlerdendir. İleri evre olmadan belirti vermeyen prostat kanserinde, erken tanı ve taramalarla iyi sonuçlar elde edilebilir. Bu çalışma erkeklerin prostat kanseri taramalarına ilişkin bilgi düzeylerini tespit etmek amacıyla yapılmıştır. Gereç ve Yöntem: Araştırma bir üniversite hastanesinin üroloji polikliniğine başvuran 120 erkek hasta ile yapılmıştır. Araştırmanın yapılabilmesi için etik kurul onayı, kurum izni ve bireylerden sözlü ve yazılı onam alınmıştır. Araştırmanın verileri; literatür taranarak oluşturulan Kişisel Bilgi Formu ve Weinrich ve arkadaşları tarafından geliştirilen "Prostat Kanseri Taramaları Bilgi Testi"(PKTBT) kullanılarak toplanmıştır.
Dyspnea is a common symptom and anxiety is a common comorbidity of chronic obstructive pulmonary disease (COPD). They affect individuals with COPD in a multifaceted way, causing many disabilities. Progressive relaxation exercises (PREs) are an important intervention in reducing symptoms and comorbidity. The aim of this study was to determine the effects of PREs on dyspnea and anxiety levels in individuals with COPD. A pretest-posttest randomized controlled trial was conducted at the chest diseases clinic of a university hospital in Turkey. Forty-four patients with COPD who met the inclusion criteria for participation in the study were assigned either to an intervention or a control group, with 22 patients in each group. In the intervention group, the patients performed PREs once a day for 4 weeks in addition to the standard treatment. The patients in the control group received the standard treatment. In the data collection stage of the study, questionnaire forms, namely, the Modified Borg Scale (MBS), Modified British Medical Research Council Dyspnea Scale, COPD Assessment Test (CAT), and Beck Anxiety Inventory (BAI), were used. Data were collected before (the first follow-up) and after the intervention (the second follow-up). In the second follow-up, the MBS, BAI, and CAT scores decreased significantly in the intervention group (P < .05) but showed no significant changes in the control group (P > .05). This study demonstrates that PREs can reduce dyspnea and anxiety levels in individuals with COPD.
Objective:
To explore health-improving behaviors during COVID-19 pandemic and to reveal the impact of the risk perception of COVID-19 on these behaviors.
Methods:
We recruited a total of 510 participants for this cross-sectional study. The data were collected online using a questionnaire booklet covering a form inquiring about the participants’ demographic, physical, and mental characteristics, the Generalized Anxiety Disorder-7 Scale, and the COVID-19 Perceived Risk Scale.
Results:
The mean age of the participants was (28.7±10.1) years, and 76.1% were females. Of the participants, 31.8% were overweight and obese. While 35.1% experienced negative alterations in their dietary patterns, 23.9% reported positive changes to their diet during the pandemic. Besides, 47.8% reported their sleep to be negatively affected during the pandemic. While the rate of those with extended screen time was 72.5%, it was 44.3% for the participants engaging in regular exercise. More than one-third of the participants (35.9%) had high and severe anxiety. We also found increased risk perception of COVID-19 among females, obese, those with disturbed eating and sleep quality, healthcare workers, and those with severe anxiety.
Conclusions:
Overall, the pandemic has appeared to have brought both positive and negative impacts on maintaining and improving eating, sleep, physical activity, and mental health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.